MedKoo Cat#: 526121 | Name: RG 6866

Description:

WARNING: This product is for research use only, not for human or veterinary use.

RG 6866 is a 5-lipoxygenase inhibitor.

Chemical Structure

RG 6866
RG 6866
CAS#120602-97-3

Theoretical Analysis

MedKoo Cat#: 526121

Name: RG 6866

CAS#: 120602-97-3

Chemical Formula: C16H17NO3

Exact Mass: 271.1208

Molecular Weight: 271.32

Elemental Analysis: C, 70.83; H, 6.32; N, 5.16; O, 17.69

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
RG 6866; RG6866; RG-6866.
IUPAC/Chemical Name
Benzeneacetamide, N-hydroxy-N-methyl-4-(phenylmethoxy)-
InChi Key
MYMPWMRYZURXNI-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H17NO3/c1-17(19)16(18)11-13-7-9-15(10-8-13)20-12-14-5-3-2-4-6-14/h2-10,19H,11-12H2,1H3
SMILES Code
O=C(N(O)C)CC1=CC=C(OCC2=CC=CC=C2)C=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 271.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Gleason MM, Rojas CJ, Learn KS, Perrone MH, Bilder GE. Characterization and inhibition of 15-lipoxygenase in human monocytes: comparison with soybean 15-lipoxygenase. Am J Physiol. 1995 May;268(5 Pt 1):C1301-7. PubMed PMID: 7762624. 2: Folcik VA, Cathcart MK. Assessment of 5-lipoxygenase involvement in human monocyte-mediated LDL oxidation. J Lipid Res. 1993 Jan;34(1):69-79. PubMed PMID: 8445344. 3: Derian CK, Lewis DF. Activation of 15-lipoxygenase by low density lipoprotein in vascular endothelial cells. Relationship to the oxidative modification of low density lipoprotein. Prostaglandins Leukot Essent Fatty Acids. 1992 Jan;45(1):49-57. PubMed PMID: 1546066. 4: Snyder DW, Cho HL, Gilmore J. Endogenously formed leukotriene C4 activates LTC4 receptors in guinea pig tracheal strips. Eur J Pharmacol. 1991 Mar 26;195(2):209-15. PubMed PMID: 1651863. 5: Jolly SR, Ordoukhani A, Movahed A. Effect of neuropeptide Y on isolated rat hearts. Pharmacology. 1991;43(3):121-7. PubMed PMID: 1775516. 6: Carnathan GW, Sweeney DM, Travis JJ, Gordon RJ, Sutherland CA, Jariwala N, Clearfield M, O'Rourke S, Huang FC, Van Inwegen RG. The inhibition of 5-lipoxygenase by RG 6866. Agents Actions. 1989 Nov;28(3-4):204-11. PubMed PMID: 2596372. 7: Jolly SR, Travis J, Van Inwegen RG. Effects of 5-lipoxygenase inhibition on cardiac anaphylaxis in isolated guinea pig hearts. Pharmacology. 1989;38(6):352-62. PubMed PMID: 2813496.